Clinical and mycological profile of cryptococcosis in a tertiary care hospital

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 401-404

  Capoor, M ^a   Nair, D ^a   Deb, M ^a   Gupta, B ^a   Aggarwal, P ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

C. gattii; C. neoformans; Cryptococcosis; HIV; Meningitis

Indexed keywords

AGAR; AMPHOTERICIN B; BROMOTHYMOL BLUE; CANNAVANINE GLYCINE BROMOTHYMOL BLUE; UNCLASSIFIED DRUG; UREA;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROLYSIS; IMMUNOCOMPETENCE; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MYCOLOGY; NONHUMAN; SPUTUM; TERTIARY HEALTH CARE; URINE;

EID: 37549064703     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37349     Document Type: Article

References (13)

1. Cox GM, Perfect JR. Cryptococcus neoformans var. neoformans and gattii and Trichosporon species. In: Topley and Wilson.s Microbiology and Microbial Infections. Ajello, Land-May RJ, editors. Arnold: London; 1999. p. 461-84.
2. Mirza HA, Phelan M, Rimland D, Graviss E, Hamll R, Brandt ME, et al. The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas 1992-2000. Clin Infect Dis 2003;36:789-94.
3. Banerjee U, Datta K, Majumdar T, Gupta K. Cryptococcosis in India: Awakening of a giant? Med Mycol 2001;39:51-67.
4. Shankar SK, Mahadevan A, Satishchandra P, Kumar RU, Yasha TC, Santosh V, et al. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 2005;121:468-88.
5. Chakrabarty A, Sharma A, Sood A, Grover R, Sakhuja V, Prabhakar S, et al. Changing scenario of cryptococcosis in a tertiary care hospital in north India. Indian J Med Res 2000;112:56-60.
6. Satpute MG, Telang NV, Litake GM, Niphadkar KB, Joshi SG. Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996-2005). J Med Microbiol 2006;55:1301-2.
7. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans. J Clin Microbiol 2005;43:2163-7.
8. nd ed, M27-A2. National Committee for Clinical Laboratory Standards, Wayne: PA; 2002.
9. Khanna N, Chandramuki A, Desai A, Ravi V. Cryptococcal infections of the central nervous system: An analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol 1996;45:376-9.
10. Bellamy R, Sangeetha S, Paton NI. AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: Results from the Singapore HIV Observational Cohort Study (SHOCS). BMC Infect Dis 2004;4:47.
11. Karstaedt AS, Crewe-Brown HH, Dromer F. Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa. Med Mycol 2002;40:7-11.
12. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 2005;11:1686-92.
13. Jenney A, Pandithage K, Fisher DA, Currie BJ. Cryptococcus infection in tropical Australia. J Clin Microbiol 2004;42:3865-8.